Quick Dispatch:
Your tirzepatide and crohn's disease Frontiers orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide and crohn's disease Frontiers ships.
Need Help?
Questions about tirzepatide and crohn's disease Frontiers, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide and crohn's disease Frontiers in your area.
COMMIT-CD: A Phase 3b trial evaluating the efficacy & safety of concomitant use of a dual GLP-1/GIP receptor agonist & IL-23p19 antagonist in adult participants with moderately to severely active Crohn's disease
27.93
Gut Hormones and Inflammatory Bowel Disease
25.95
The Potential for GLP-1s in the Treatment of Crohn's Disease
27.08
The Impact of Obesity on Inflammatory Bowel Disease
23.13
New research published in the Foundation's journal Crohn's & Colitis 360 found that people with IBD who use GLP-1 medications—commonly prescribed for diabetes and obesity—had a lower risk of major heart-related complications
23.96
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight (COMMIT-CD)
25.32
GLP-1 for Crohn's Disease: Current Evidence and Treatment Options
28.50
